ID22348A - Tablet-tablet terlapis lapisan tipis yang mengandung oksakarbazepin - Google Patents

Tablet-tablet terlapis lapisan tipis yang mengandung oksakarbazepin

Info

Publication number
ID22348A
ID22348A IDW990810A ID990810A ID22348A ID 22348 A ID22348 A ID 22348A ID W990810 A IDW990810 A ID W990810A ID 990810 A ID990810 A ID 990810A ID 22348 A ID22348 A ID 22348A
Authority
ID
Indonesia
Prior art keywords
oksakarbazepin
taped
tablets
thin layers
layers containing
Prior art date
Application number
IDW990810A
Other languages
English (en)
Indonesian (id)
Inventor
Burkhard Schlutermann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4184588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22348(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID22348A publication Critical patent/ID22348A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IDW990810A 1997-02-14 1998-02-12 Tablet-tablet terlapis lapisan tipis yang mengandung oksakarbazepin ID22348A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH33197 1997-02-14

Publications (1)

Publication Number Publication Date
ID22348A true ID22348A (id) 1999-09-30

Family

ID=4184588

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990810A ID22348A (id) 1997-02-14 1998-02-12 Tablet-tablet terlapis lapisan tipis yang mengandung oksakarbazepin

Country Status (31)

Country Link
US (2) US20070036863A1 (cs)
EP (1) EP0966287B1 (cs)
JP (3) JP2000511935A (cs)
KR (3) KR19980071337A (cs)
CN (2) CN1170542C (cs)
AR (1) AR011142A1 (cs)
AT (1) ATE239481T1 (cs)
AU (1) AU738030B2 (cs)
BR (1) BR9807368A (cs)
CA (1) CA2277791C (cs)
CO (1) CO4920215A1 (cs)
CY (1) CY2480B1 (cs)
CZ (1) CZ298840B6 (cs)
DE (1) DE69814367T2 (cs)
DK (1) DK0966287T3 (cs)
ES (1) ES2199422T3 (cs)
HU (1) HU227807B1 (cs)
ID (1) ID22348A (cs)
MY (1) MY117582A (cs)
NO (1) NO327486B1 (cs)
NZ (1) NZ336946A (cs)
PE (1) PE58999A1 (cs)
PL (1) PL193332B1 (cs)
PT (1) PT966287E (cs)
RU (1) RU2201218C2 (cs)
SK (1) SK284503B6 (cs)
TR (1) TR199901804T2 (cs)
TW (1) TW529957B (cs)
UY (1) UY24888A1 (cs)
WO (1) WO1998035681A1 (cs)
ZA (1) ZA981205B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
NZ532707A (en) 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
CA2537060A1 (en) 2003-09-03 2005-03-10 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
US8367105B2 (en) 2004-11-10 2013-02-05 Teva Pharmaceutical Industries, Ltd. Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
DE602006011485D1 (de) * 2005-09-23 2010-02-11 Hoffmann La Roche Neue dosierformulierung
DK2774925T3 (en) 2005-11-08 2017-02-27 Vertex Pharma Heterocyclic modulators of ATP binding cassette transporters
US9034381B2 (en) 2005-11-10 2015-05-19 Alphapharm Pty Ltd Process to control particle size
AU2006313009B2 (en) * 2005-11-10 2013-10-24 Alphapharm Pty Ltd Process to control particle size
CA2630240A1 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
JP2008540346A (ja) * 2006-01-31 2008-11-20 テバ ファーマシューティカル インダストリーズ リミティド オキシカルバゼピンの医薬製剤及びその調製方法
EP2010499A4 (en) * 2006-04-21 2012-07-18 Alphapharm Pty Ltd PHARMACEUTICAL COMPOSITION OF OXCARBAZEPINE PARTICULATE FROM 15 TO 30 MICRONS IN AVERAGE
WO2007122635A2 (en) 2006-04-26 2007-11-01 Astron Research Limited Controlled release formulation comprising anti-epileptic drugs
CN101489560B (zh) * 2006-04-26 2015-11-25 苏佩努斯制药公司 具有s形释放曲线的奥卡西平控释制剂
US20080138403A1 (en) * 2006-12-08 2008-06-12 Sun Pharmaceutical Industries Ltd. Pharmaceutical dosage forms of oxcarbazepine
US20100104636A1 (en) 2006-12-21 2010-04-29 Panagiotis Keramidas Pharmaceutical Compound and Composition
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
EP2146699A2 (en) * 2007-05-23 2010-01-27 Ratiopharm GmbH Pharmaceutical compositions comprising oxcarbazepine
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
KR20160040745A (ko) 2007-12-07 2016-04-14 버텍스 파마슈티칼스 인코포레이티드 3-(6-(1-(2,2-디플루오로벤조[ｄ][1,3]디옥솔-5-일)사이클로프로판카복스아미도)-3-메틸피리딘-2-일)벤조산의 고체 형태
NZ708598A (en) 2010-04-07 2017-05-26 Vertex Pharma Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d](1,3)dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
RU2718044C2 (ru) 2013-11-12 2020-03-30 Вертекс Фармасьютикалз Инкорпорейтед Способ получения фармацевтических композиций для лечения опосредованных cftr заболеваний
CN103735527B (zh) * 2013-12-24 2014-09-10 武汉人福药业有限责任公司 一种奥卡西平片剂及其制备方法
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
TWI853027B (zh) 2019-05-16 2024-08-21 瑞士商諾華公司 N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
JPS6257467A (ja) * 1985-09-06 1987-03-13 Asahi Glass Co Ltd コ−テイング剤組成物
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5478654A (en) * 1994-05-06 1995-12-26 Gencorp Inc. Solventless carboxylated butadiene-vinylidene chloride adhesives for bonding rubber to metal
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones

Also Published As

Publication number Publication date
US20070036863A1 (en) 2007-02-15
SK109899A3 (en) 2000-03-13
TW529957B (en) 2003-05-01
JP2010132694A (ja) 2010-06-17
CA2277791A1 (en) 1998-08-20
PE58999A1 (es) 1999-06-25
EP0966287A1 (en) 1999-12-29
DK0966287T3 (da) 2003-08-25
KR20090037873A (ko) 2009-04-16
AU6622298A (en) 1998-09-08
PT966287E (pt) 2003-09-30
CZ287999A3 (cs) 1999-11-17
DE69814367D1 (de) 2003-06-12
BR9807368A (pt) 2000-03-14
CZ298840B6 (cs) 2008-02-20
JP2006077029A (ja) 2006-03-23
ES2199422T3 (es) 2004-02-16
CA2277791C (en) 2008-11-18
CN1247471A (zh) 2000-03-15
NO327486B1 (no) 2009-07-13
KR19980071337A (ko) 1998-10-26
KR20120079826A (ko) 2012-07-13
CY2480B1 (en) 2005-06-03
DE69814367T2 (de) 2004-02-26
HUP0000886A3 (en) 2002-10-28
HUP0000886A2 (hu) 2000-09-28
AU738030B2 (en) 2001-09-06
CN1170542C (zh) 2004-10-13
PL193332B1 (pl) 2007-02-28
CO4920215A1 (es) 2000-05-29
NO993919L (no) 1999-08-13
UY24888A1 (es) 2000-12-29
ZA981205B (en) 1998-08-14
HU227807B1 (en) 2012-03-28
JP2000511935A (ja) 2000-09-12
ATE239481T1 (de) 2003-05-15
SK284503B6 (sk) 2005-05-05
EP0966287B1 (en) 2003-05-07
RU2201218C2 (ru) 2003-03-27
NZ336946A (en) 2001-02-23
NO993919D0 (no) 1999-08-13
US20080014269A1 (en) 2008-01-17
HK1024423A1 (en) 2000-10-13
PL334959A1 (en) 2000-03-27
AR011142A1 (es) 2000-08-02
WO1998035681A1 (en) 1998-08-20
CN1626093A (zh) 2005-06-15
TR199901804T2 (xx) 1999-09-21
MY117582A (en) 2004-07-31

Similar Documents

Publication Publication Date Title
ID22348A (id) Tablet-tablet terlapis lapisan tipis yang mengandung oksakarbazepin
DE69426971D1 (de) Mikrolinsensubstrat
FI962833A7 (fi) Elektroluminesenssi-ohutkalvolaite
FI961534A0 (fi) Sähköä eristävä kalvotausta
DE69833444T8 (de) Verbundfolie
BR9407542A (pt) Dispositivos elétricos
DE69932109D1 (de) Antireflektierende Schichten
ID22047A (id) Film poliester yang diorientasikan secara biaksial
DE69813059D1 (de) Dunnschicht-Fluoropolymer enthaltendes elektronisches System
DE69705021D1 (de) Wasserstoffdünnschichtsensor
DE59609022D1 (de) Verbindungssubstrat
ID23200A (id) Film poliester yang diorientasikan secara biaksial
DE69421696D1 (de) Dreischicht-polyimidsiloxan klebeband
ID18709A (id) Film polipropilena yang diorientasikan secara biaksial
ZA981447B (en) Thin films
DE59803050D1 (de) Mehrlagiges Klebeband
DE69406578D1 (de) Dünnschicht-Elektrolumineszenzvorrichtung
DK0695387T3 (da) Nødboligkonstruktion
EP0826248A4 (en) Electrochemical light-emitting devices
FR2778867B1 (fr) Film laminateur
DE69736284D1 (de) Wasserfeste Filmschicht
FI946079A7 (fi) Juurenkestävä kantajakerrosrakenne
DE69805554D1 (de) Filmverarbeitungsgerät
ITRM960397A0 (it) Composti organici (caso 153-5863)
DE19782248T1 (de) Notfall-Evakuierungseinrichtung